Life Sciences

Galecto announces first patient enrolled in phase 2 trial of GB1211 in combination with Atezolizumab for first-line treatment of NSCLC
23 June 2022

Galecto announces first patient enrolled in phase 2 trial of GB1211 in combination with Atezolizumab for first-line treatment of NSCLC

GB1211, Galecto's galectin-3 inhibitor, has shown potent anti-tumor effects and increased efficacy of checkpoint inhibition in pre-clinical models

Read the press release
MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.
15 December 2021

MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.

MDoloris Medical Systems, leader in the field of objective analgesia/nociception monitoring during anesthesia and in intensive care, and Mindray, a global leader in developing...

Read the press release
MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan
17 November 2021

MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan

MDoloris Medical Systems, a leader in the field of objective pain monitoring during anesthesia, announces today the regulatory clearance and marketing approval of its HFVI...

Read the press release
Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials
14 July 2021

Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials

Dopavision, a company pioneering the development of digital therapeutics, today announced the closing of a €12 million Series A financing round. Seventure Partners led the...

Read the press release
Mdoloris Announces CE Marking of the Analgesia Nociception Index (ANI®) Module for the Masimo Root® Patient Monitoring and Connectivity Hub
29 April 2019

Mdoloris Announces CE Marking of the Analgesia Nociception Index (ANI®) Module for the Masimo Root® Patient Monitoring and Connectivity Hub

ANI provides an objective, noninvasive, and continuous way to automatically monitor the pain level of patients. The Root platform, with its open architecture and built-in...

Read the press release
Novartis reimagines neurosciences by developing smart templates that measure progression in MS patients, in collaboration with FeetMe and the Vithas Nisa Foundation
20 December 2018

Novartis reimagines neurosciences by developing smart templates that measure progression in MS patients, in collaboration with FeetMe and the Vithas Nisa Foundation

Specialized in smart medical devices, FeetMe focused on the development of portable insoles that measure progression in patients with multiple sclerosis (MS).

Read the press release
Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery
25 July 2018

Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery

Clinical phase III trial at 6 specialized liver centers demonstrates impressive benefits of the LiMAx® test.

Read the press release
The LiMAx® liver capacity test is now commercially available in Germany, Austria and the UK
12 April 2018

The LiMAx® liver capacity test is now commercially available in Germany, Austria and the UK

Humedics GmbH, a specialist in real-time measurement of individual liver function, today announced that the company has received Marketing Authorization for its diagnostic...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse